
|Articles|September 1, 2003
Pfizer competitors quietly explore surgical business
New York-Potential suitors are lining up to express interest in the probable sale of Pfizer Inc.'s surgical ophthalmology business, but so far, no one is proposing-publicly.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: The evolution of eye care on display at AAO 2025
4
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
5